Walgreens Boots Alliance Inc (WBA) Shares Sold by Lido Advisors LLC

Lido Advisors LLC lowered its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 5.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 15,680 shares of the pharmacy operator’s stock after selling 903 shares during the quarter. Lido Advisors LLC’s holdings in Walgreens Boots Alliance were worth $1,039,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. Hudock Capital Group LLC lifted its position in Walgreens Boots Alliance by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 6 shares during the period. Northern Capital Management LLC lifted its position in Walgreens Boots Alliance by 0.4% during the 2nd quarter. Northern Capital Management LLC now owns 6,635 shares of the pharmacy operator’s stock valued at $520,000 after purchasing an additional 25 shares during the period. MAI Capital Management lifted its position in Walgreens Boots Alliance by 0.6% during the 2nd quarter. MAI Capital Management now owns 5,272 shares of the pharmacy operator’s stock valued at $413,000 after purchasing an additional 34 shares during the period. Truepoint Inc. lifted its position in Walgreens Boots Alliance by 0.5% during the 2nd quarter. Truepoint Inc. now owns 8,614 shares of the pharmacy operator’s stock valued at $698,000 after purchasing an additional 39 shares during the period. Finally, Meridian Wealth Management LLC lifted its position in Walgreens Boots Alliance by 1.4% during the 1st quarter. Meridian Wealth Management LLC now owns 3,550 shares of the pharmacy operator’s stock valued at $295,000 after purchasing an additional 50 shares during the period. 61.18% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $73.42 on Wednesday. The firm has a market cap of $72,710.00, a P/E ratio of 20.28, a P/E/G ratio of 1.29 and a beta of 1.22. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47. Walgreens Boots Alliance Inc has a 52-week low of $63.82 and a 52-week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.01. The business had revenue of $30.74 billion for the quarter, compared to the consensus estimate of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. Walgreens Boots Alliance’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period last year, the company posted $1.10 EPS. research analysts predict that Walgreens Boots Alliance Inc will post 5.59 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Monday, November 13th were given a $0.40 dividend. The ex-dividend date of this dividend was Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.18%. Walgreens Boots Alliance’s dividend payout ratio is 44.20%.

Walgreens Boots Alliance announced that its Board of Directors has approved a stock repurchase program on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to repurchase shares of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board believes its stock is undervalued.

A number of research analysts have issued reports on WBA shares. Morgan Stanley downgraded shares of Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating and cut their target price for the company from $95.00 to $85.00 in a research report on Friday, October 6th. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, November 10th. Vetr upgraded shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, December 12th. Robert W. Baird restated an “outperform” rating and set a $80.00 target price (down from $90.00) on shares of Walgreens Boots Alliance in a research report on Thursday, October 19th. They noted that the move was a valuation call. Finally, Citigroup cut their target price on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating on the stock in a research report on Thursday, November 2nd. One investment analyst has rated the stock with a sell rating, eight have given a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $86.05.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the sale, the director now directly owns 16,415 shares in the company, valued at approximately $1,105,878.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director John Anthony Lederer bought 20,000 shares of the company’s stock in a transaction on Thursday, October 26th. The shares were bought at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the acquisition, the director now directly owns 50,000 shares in the company, valued at approximately $3,350,000. The disclosure for this purchase can be found here. Company insiders own 14.80% of the company’s stock.

WARNING: This article was published by Markets Daily and is the property of of Markets Daily. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States & international copyright legislation. The original version of this article can be read at https://www.themarketsdaily.com/2018/01/10/walgreens-boots-alliance-inc-wba-shares-sold-by-lido-advisors-llc.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply